Macular Degeneration Treatment Market 2023 | Share, Growth Outook, Research Report 2028

 How Big is the Macular Degeneration Treatment Market ?

IMARC Group’s latest report, titled “Macular Degeneration Treatment Market: Global Industry Trends, Share, Size, Growth, Opportunity and Forecast 2023-2028”, the global macular degeneration treatment market size reached US$ 8.9 Billion in 2022. Looking forward, IMARC Group expects the market to reach US$ 12.9 Billion by 2028, exhibiting a growth rate (CAGR) of 6.2% during 2023-2028.

What is Macular Degeneration Treatment ?

Macular degeneration treatment refers to medical interventions and therapies that focus on managing and mitigating the effects of macular degeneration, which is a progressive eye condition. It comprises a range of strategies, such as medication, surgical procedures, and lifestyle modifications, to improve visual function in individuals afflicted by this condition. It can be treated through anti-angiogenic drugs that prevent blockages and leakages in the blood vessels.   

Request Free Sample Report (Exclusive Offer on this report): https://www.imarcgroup.com/macular-degeneration-treatment-market/requestsample


Who are the key Players Operating in the Industry ? :

  • Aerie Pharmaceuticals Inc.
  • Bausch Health Companies Inc.
  • Bayer AG
  • F. Hoffmann-La Roche Ltd
  • Iveric Bio Inc.
  • Novartis AG
  • Panoptica
  • Pfizer Inc.
  • Phio Pharmaceuticals
  • Regeneron Pharmaceuticals Inc.
  • Regenxbio Inc.
  • Santen Pharmaceutical Co. Ltd.

What are the Growth Prospects and Trends in the Macular Degeneration Treatment Industry ? :

At present, the rising awareness about the importance of early disease detection among individuals, along with the improved diagnostic methods that enhance treatment effectiveness, represents one of the major factors strengthening the growth of the market.

Besides this, the increasing preference for gene therapy and regenerative medicine that offer promising prospects for innovative macular degeneration is contributing to the growth of the market. Moreover, the rising popularity of personalized medicine to improve patient outcomes due to the increasing focus on patient-centric approaches in healthcare facilities worldwide is bolstering the growth of the market.

Apart from this, the growing demand for effective treatments and therapies due to the rising incidences of macular degeneration among individuals across the globe is positively influencing the market. In line with this, the increasing number of insurance coverage policies for eye care and treatments to reduce financial barriers for patients is supporting the growth of the market.  

Ask Analyst for Instant Discount and Download Full Report with TOC & List of Figure: https://www.imarcgroup.com/macular-degeneration-treatment-market

Key Market Segmentation:

Breakup by Type:

  • Dry Age-related Macular Degeneration
  • Wet Age-related Macular Degeneration

Breakup by Stage of Disease:

  • Early Stage
  • Intermediate Stage
  • Late Stage

Breakup by Route of Administration:

  • Intravenous Route
  • Intravitreal Route

Breakup by End User:

  • Hospitals
  • Ambulatory Surgical Center
  • Others

Breakup by Region:

  • North America (United States, Canada)
  • Asia Pacific (China, Japan, India, Australia, Indonesia, Korea, Others)
  • Europe (Germany, France, United Kingdom, Italy, Spain, Others)
  • Latin America (Brazil, Mexico, Others)
  • Middle East and Africa (United Arab Emirates, Saudi Arabia, Qatar, Iraq, Other)

Key Highlights of the Report: 

  • Market Performance (2017-2022)
  • Market Outlook (2023-2028)
  • Porter’s Five Forces Analysis
  • Market Drivers and Success Factors
  • SWOT Analysis
  • Value Chain
  • Comprehensive Mapping of the Competitive Landscape 

About Us: 

IMARC Group is a leading market research company that offers management strategy and market research worldwide. We partner with clients in all sectors and regions to identify their highest-value opportunities, address their most critical challenges, and transform their businesses. 

IMARC’s information products include major market, scientific, economic and technological developments for business leaders in pharmaceutical, industrial, and high technology organizations. Market forecasts and industry analysis for biotechnology, advanced materials, pharmaceuticals, food and beverage, travel and tourism, nanotechnology and novel processing methods are at the top of the company’s expertise.

Contact us:

IMARC Group

134 N 4th St. Brooklyn, NY 11249, USA

Email: sales@imarcgroup.com

Tel No:(D) +91 120 433 0800

Americas:- +1 631 791 1145 | Africa and Europe :- +44-702-409-7331 | Asia: +91-120-433-0800, +91-120-433-0800 

Popular posts from this blog

GCC LED Lighting Market Size, Trends, Growth, Forecast & Industry Report 2024-2032

Blood Group Typing Market Size, Key Facts, Dynamics, Segments and Forecast Report 2023-2028

Global Civil Engineering Market Size to Grow at a CAGR of 5.2% in the Forecast Period of 2023-2028